Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.32 | 8.23 | 11.14 | 7.63 | 9.78 | 8.82 | 7.76 | 7.56 | 8.82 | 7.45 | 11.89 | 6.93 |
| Expenses | 7.62 | 6.77 | 8.87 | 6.77 | 8.16 | 7.25 | 7.75 | 7.23 | 6.70 | 6.94 | 9.05 | 6.24 |
| Operating Profit | 1.70 | 1.46 | 2.27 | 0.86 | 1.62 | 1.57 | 0.01 | 0.33 | 2.12 | 0.51 | 2.84 | 0.69 |
| OPM % | 18.24% | 17.74% | 20.38% | 11.27% | 16.56% | 17.80% | 0.13% | 4.37% | 24.04% | 6.85% | 23.89% | 9.96% |
| Other Income | 0.27 | 0.50 | 0.74 | 0.45 | 0.53 | 0.54 | 0.83 | 0.68 | 0.86 | 0.67 | 0.69 | 0.37 |
| Interest | 0.03 | 0.01 | 0.07 | 0.06 | 0.08 | 0.06 | 0.08 | 0.14 | 0.09 | 0.10 | 0.08 | 0.05 |
| Depreciation | 0.06 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.11 | 0.13 |
| Profit before tax | 1.88 | 1.87 | 2.86 | 1.17 | 1.98 | 1.96 | 0.66 | 0.77 | 2.78 | 0.97 | 3.34 | 0.88 |
| Tax % | 26.06% | 26.20% | 25.52% | 25.64% | 26.26% | 26.02% | 31.82% | 25.97% | 25.90% | 25.77% | 25.75% | 26.14% |
| Net Profit | 1.39 | 1.38 | 2.13 | 0.86 | 1.47 | 1.45 | 0.45 | 0.57 | 2.06 | 0.72 | 2.48 | 0.65 |
| EPS in Rs | 4.37 | 4.34 | 6.70 | 2.71 | 4.63 | 4.56 | 1.42 | 1.79 | 6.48 | 2.27 | 7.80 | 2.05 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.27 | 15.41 | 16.58 | 19.71 | 21.17 | 22.68 | 26.70 | 37.88 | 36.96 | 33.99 | 35.72 | 35.09 |
| Expenses | 13.97 | 13.76 | 14.78 | 18.55 | 18.33 | 19.57 | 24.49 | 32.32 | 30.53 | 29.88 | 29.88 | 28.93 |
| Operating Profit | 1.30 | 1.65 | 1.80 | 1.16 | 2.84 | 3.11 | 2.21 | 5.56 | 6.43 | 4.11 | 5.84 | 6.16 |
| OPM % | 8.51% | 10.71% | 10.86% | 5.89% | 13.42% | 13.71% | 8.28% | 14.68% | 17.40% | 12.09% | 16.35% | 17.55% |
| Other Income | 0.25 | 0.44 | 7.74 | 1.04 | 1.15 | 0.99 | 1.04 | 2.30 | 1.94 | 2.35 | 2.90 | 2.59 |
| Interest | 0.57 | 0.39 | 0.17 | 0.08 | 0.06 | 0.09 | 0.09 | 0.25 | 0.21 | 0.34 | 0.45 | 0.32 |
| Depreciation | 0.56 | 0.56 | 0.32 | 0.05 | 0.03 | 0.05 | 0.12 | 0.13 | 0.26 | 0.36 | 0.43 | 0.46 |
| Profit before tax | 0.42 | 1.14 | 9.05 | 2.07 | 3.90 | 3.96 | 3.04 | 7.48 | 7.90 | 5.76 | 7.86 | 7.97 |
| Tax % | 45.24% | 59.65% | 28.07% | 29.95% | 23.59% | 25.76% | 28.62% | 25.27% | 25.82% | 26.39% | 26.46% | |
| Net Profit | 0.24 | 0.46 | 6.52 | 1.45 | 2.99 | 2.94 | 2.17 | 5.59 | 5.86 | 4.25 | 5.79 | 5.91 |
| EPS in Rs | 0.76 | 1.45 | 20.51 | 4.56 | 9.41 | 9.25 | 6.83 | 17.59 | 18.44 | 13.37 | 18.22 | 18.60 |
| Dividend Payout % | 0.00% | 69.13% | 4.88% | 21.93% | 15.95% | 16.22% | 14.65% | 0.00% | 0.00% | 14.96% | 10.98% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 9% | 10% | -2% | 3% | ||
| Compounded Profit Growth | 37% | 15% | 1% | 50% | ||
| Stock Price CAGR | 17% | -3% | -8% | -16% | ||
| Return on Equity | 15% | 16% | 16% | 15% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 |
| Reserves | 3.72 | 3.96 | 4.04 | 10.56 | 11.63 | 14.23 | 16.69 | 18.36 | 23.64 | 28.76 | 32.38 | 37.70 |
| Borrowings | 5.58 | 5.01 | 3.10 | 1.41 | 0.46 | 0.00 | 0.00 | 1.31 | 4.02 | 1.95 | 4.21 | 1.81 |
| Other Liabilities | 4.16 | 3.21 | 3.13 | 5.23 | 5.56 | 7.28 | 3.14 | 2.66 | 3.68 | 3.41 | 3.30 | 5.19 |
| Total Liabilities | 16.64 | 15.36 | 13.45 | 20.38 | 20.83 | 24.69 | 23.01 | 25.51 | 34.52 | 37.30 | 43.07 | 47.88 |
| Fixed Assets | 7.62 | 7.28 | 6.78 | 0.10 | 0.20 | 0.30 | 0.67 | 0.91 | 0.86 | 2.43 | 2.49 | 2.35 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.23 | 0.18 | 0.07 | 1.10 | 1.23 | 0.97 | 1.12 | 0.32 | 0.00 | 1.16 | 2.35 | 2.51 |
| Other Assets | 8.79 | 7.90 | 6.60 | 19.18 | 19.40 | 23.42 | 21.22 | 24.28 | 33.66 | 33.71 | 38.23 | 43.02 |
| Total Assets | 16.64 | 15.36 | 13.45 | 20.38 | 20.83 | 24.69 | 23.01 | 25.51 | 34.52 | 37.30 | 43.07 | 47.88 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1.56 | 1.32 | 2.42 | -10.70 | 0.43 | 0.36 | 0.22 | 7.90 | -6.50 | 6.03 | -5.83 | -1.58 |
| Cash from Investing Activity | -2.02 | -0.06 | 0.07 | 13.30 | 0.53 | 1.02 | 0.16 | 1.39 | 1.27 | -1.32 | 0.46 | 2.01 |
| Cash from Financing Activity | 0.46 | -1.28 | -2.24 | -2.26 | -1.36 | -0.87 | -0.49 | 0.79 | 2.19 | -2.88 | 1.35 | -3.44 |
| Net Cash Flow | 0.00 | -0.01 | 0.24 | 0.33 | -0.41 | 0.50 | -0.12 | 10.08 | -3.04 | 1.83 | -4.02 | -3.01 |
| Free Cash Flow | -0.50 | 1.10 | 2.38 | 3.34 | 0.29 | 0.23 | -0.20 | 7.55 | -6.58 | 4.20 | -6.25 | -1.88 |
| CFO/OP | 117% | 114% | 164% | -457% | 153% | 36% | 51% | 397% | -95% | 125% | -78% | -13% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74.39 | 93.22 | 89.53 | 131.65 | 94.63 | 107.41 | 99.30 | 100.34 | 77.57 | 61.43 | 44.56 | 76.23 |
| Inventory Days | 45.71 | 53.90 | 69.11 | 64.32 | 60.51 | 59.00 | 48.01 | 57.91 | 79.48 | 38.86 | 44.33 | 36.74 |
| Days Payable | 59.78 | 31.68 | 52.91 | 62.28 | 45.28 | 59.39 | 76.61 | 57.65 | 48.68 | 40.43 | 42.91 | 67.68 |
| Cash Conversion Cycle | 60.32 | 115.44 | 105.73 | 133.69 | 109.85 | 107.02 | 70.70 | 100.60 | 108.36 | 59.85 | 45.98 | 45.29 |
| Working Capital Days | 11.90 | 12.43 | 14.69 | 258.67 | 245.56 | 267.41 | 143.88 | 127.82 | 174.50 | 193.76 | 274.47 | 344.26 |
| ROCE % | 12.04% | 8.04% | 13.44% | 14.21% | 14.14% | 23.75% | 21.73% | 12.92% | 28.79% | 25.06% | 16.56% | 20.16% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% | 61.98% |
| Public | 38.01% | 38.02% | 38.02% | 38.02% | 38.02% | 38.02% | 38.01% | 38.02% | 38.02% | 38.01% | 38.01% | 38.02% |
| No. of Shareholders | 5,575 | 5,510 | 5,395 | 5,627 | 6,175 | 6,330 | 6,323 | 6,328 | 6,237 | 6,080 | 6,006 | 5,977 |
Fundamentals
Market Cap₹ 50.0 Cr.
Current Price₹ 158
Stock P/E8.47
Book Value₹ 129
ROCE20.2 %
ROE15.2 %
Dividend Yield1.28 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)3%
Compounded Profit Growth (TTM)50%
Standalone figures.
Valuation
Market capRs 46 Cr
Enterprise valueRs 45 Cr
P/E (TTM)7.77x
Price to book1.12x
Price to sales1.31x
EV / EBITDA5.16x
EV / EBIT5.45x
EV / sales1.29x
Earnings yield12.88%
Dividend yield1.39%
P/E, 3-year average11.17x
P/B, 3-year average1.60x
P/E, 5-year average11.51x
P/B, 5-year average1.60x
Profitability
Operating margin (excl. other income)16.35%
Operating margin (incl. other income)24.47%
EBITDA margin24.94%
Pre-tax margin22.71%
Net profit margin16.84%
Net margin, latest quarter9.38%
ROE15.15%
ROCE20.16%
ROA12.73%
ROE, 3-year average15.90%
ROCE, 3-year average20.59%
ROA, 3-year average13.21%
ROE, 5-year average16.26%
ROCE, 5-year average21.04%
ROA, 5-year average13.44%
ROIC (approx.)15.18%
Tax rate26.46%
Other income / net worth7.09%
Growth
Sales growth (latest year)5.09%
Profit growth (latest year)36.24%
Sales CAGR, 3 years-1.94%
Sales CAGR, 5 years9.51%
Profit CAGR, 3 years1.18%
Profit CAGR, 5 years14.52%
Sales growth QoQ-41.72%
Profit growth QoQ-73.79%
Sales growth YoY (latest quarter)-8.33%
Profit growth YoY (latest quarter)14.04%
Per share
EPS (TTM)Rs 18.60
EPS (latest year)Rs 18.22
EPS (latest quarter)Rs 2.05
EPS, 3-year averageRs 16.68
EPS, 5-year averageRs 14.89
Book value per shareRs 128.63
Sales per shareRs 110.41
Cash flow per shareRs -4.97
Free cash flow per shareRs -5.92
Dividend per share (latest year)Rs 2.01
Dividend per share, 3-year averageRs 2.01
Dividend per share, 5-year averageRs 1.68
Dividends
Dividend payout11.05%
Dividend payout, 3-year average13.06%
Dividend payout, 5-year average13.62%
Efficiency
Asset turnover0.75x
Fixed asset turnover15.20x
Inventory turnover13.19x
Inventory days28 days
Debtor days76 days
Debtors turnover4.79x
Creditor days68 days
Cash conversion cycle45 days
Working capital days344 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 3 Cr
Net debtRs -1 Cr
Debt to equity0.04x
Net debt / EBITDA-0.08x
Interest coverage25.91x
Owners' fund to total sources85.38%
Debt to assets3.78%
Cash flow
Cash from Operating Activity (latest year)Rs -2 Cr
Cash from Investing Activity (latest year)Rs 2 Cr
Cash from Financing Activity (latest year)Rs -3 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs -2 Cr
FCFE (approx.: FCF + change in debt)Rs -4 Cr
Cash from ops / profit, 5 years0.00x
Statement figures
Net sales (TTM)Rs 35 Cr
Net sales (latest year)Rs 36 Cr
Sales (latest quarter)Rs 7 Cr
Operating profit excl. other income (latest year)Rs 6 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 3 Cr
EBITDA (TTM)Rs 9 Cr
PBDT (TTM)Rs 8 Cr
Profit before tax (TTM)Rs 8 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 6 Cr
Net profit (latest year)Rs 6 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 20 Cr
Total expenditure (latest year)Rs 30 Cr
Total income (latest year)Rs 39 Cr
Share capitalRs 3 Cr
ReservesRs 38 Cr
Shareholders' fundsRs 41 Cr
Total assetsRs 48 Cr
Net blockRs 2 Cr
InvestmentsRs 3 Cr
ReceivablesRs 7 Cr
InventoryRs 2 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)0.32
Ownership
Promoter holding61.98% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 7.8 is at the 26th percentile of its own 9.3-year range
(median 12.1, low 1.6, high 36.2).
P/B 1.12 is at the 22th percentile (median 1.65).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 538634 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -9.7% | -2.8% | -6.9 pts |
| 1 month | -6.8% | -6.8% | -0.0 pts |
| 3 months | -14.6% | -7.6% | -7.0 pts |
| 3 years | -24.4% | +14.2% | -38.6 pts |
| 5 years | -15.7% | +27.9% | -43.6 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was -9% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 15% of total assets in 2026 |
| explain | Receivables outrunning sales Receivables grew 80% vs sales +5% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹7 Cr -8.3% vs Jun 2025.
Net profit ₹1 Cr +14.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Vasundhara Rasayans Ltd?
Vasundhara Rasayans Ltd (538634) has a market capitalisation of Rs 50.0 Cr. at the 2026-10-01 close.
What is the P/E ratio of Vasundhara Rasayans Ltd?
Vasundhara Rasayans Ltd trades at a P/E of 8.47 on trailing twelve-month profit, at the 2026-10-01 close.
What were Vasundhara Rasayans Ltd's latest quarterly results?
In the Jun 2026 quarter, Vasundhara Rasayans Ltd sales was Rs 7 Cr (-8.3% vs Jun 2025) and net profit was Rs 1 Cr.